Shi-Qiang Cao

Shi-Qiang Cao

Auto-generated profile, based on publicly available information

Shi-Qiang Cao

Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2024 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
SCShi-Qiang Cao
Shi-Qiang Cao
SXSong-Tao Xue
Song-Tao Xue
WLWen-Juan Li
Wen-Juan Li
GHGuo-Sheng Hu
Guo-Sheng Hu
ZWZhi-Gang Wu
Zhi-Gang Wu
BZBin Zheng
Bin Zheng
The oncogenic role of circRNA in cancers including esophageal cancer (EC) has been well studied. However, whether and how circRNAs are involved in cancer cell metabolic processes remains largely unknown. Here, we reported that circRNA, circHIPK3, is highly expressed in ESCC cell lines and tissues. Knockdown of circHIPK3 significantly restrained cell proliferation, colony formation, migration, and invasion in vitro and inhibited tumor growth in vivo. Mechanistically, circHIPK3 was found to act as a ceRNA by sponging miR-637 to regulate FASN expression and fatty acid metabolism in ESCC cells. Anti-sense oligonucleotide (ASO) targeting circHIPK3 substantially inhibited ESCC both in vitro and in vivo. Therefore, these results uncover a modulatory axis constituting of circHIPK3/miR-637/FASN may be a potential biomarker and therapeutic target for ESCC in the clinic.